HLA
EDIT icon

Hamilton Lane Advisors’s Editas Medicine EDIT Stock Holding History

Hamilton Lane Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-19,323
Closed -$314K – 64
2016
Q4 		$314K Hold
19,323
– – 0.21% 50
2016
Q3 		$260K Buy
+19,323
New +$396K 0.13% 55

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hamilton Lane Advisors's EDIT Position: Q1 2017 in Review

Hamilton Lane Advisors sold out of Editas Medicine (EDIT) in Q1 2017, closing a stake of 19,323 shares — an estimated $314K sold.

Hamilton Lane Advisors first reported a position in EDIT in Q3 2016 and held it in 2 quarters. The position peaked at $314K in Q4 2016. 99 funds tracked by Wall St. Rank hold EDIT as of Q1 2017.

  • Hamilton Lane Advisors reported no remaining Editas Medicine position as of Q1 2017 after selling out during the quarter.
  • Hamilton Lane Advisors sold 19,323 Editas Medicine shares in Q1 2017, an estimated $314K.
  • Hamilton Lane Advisors first reported a position in Editas Medicine in Q3 2016 and held it in 2 quarters.
  • Hamilton Lane Advisors's Editas Medicine position peaked at $314K in Q4 2016.
  • 99 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2017.

Based on Hamilton Lane Advisors's 13F filing for Q1 2017, filed 24 Apr 2017.